SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hallmans Göran) ;pers:(Weinehall Lars);mspu:(article)"

Sökning: WFRF:(Hallmans Göran) > Weinehall Lars > Tidskriftsartikel

  • Resultat 1-10 av 29
  • [1]23Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • de Faire, Ulf, et al. (författare)
  • Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden
  • 2010
  • Ingår i: Stroke. - 0039-2499. ; 41:4, s. 607-612
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND PURPOSE: Natural immunoglobulin M antibodies specific for phosphorylcholine (anti-PC) have been implicated in atherosclerosis. We have shown previously that high levels of anti-PC predict a slower progression of atherosclerosis in humans and that low levels of anti-PC are associated with higher risk for cardiovascular disease. Here we determine the association between anti-PC and the incidence of stroke. METHODS: Using a nested case control study design, we examined 227 incident cases (125 men and 102 women) of first-time stroke and 455 age- and sex-matched controls identified during a 13-year time period (1985 to 1999) within the population-based cohorts of the Västerbotten Intervention Project (VIP) and the World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease (WHO MONICA) project in Northern Sweden. Odds ratios of stroke with 95% CIs with adjustments for age, gender, smoking, serum cholesterol, diabetes, body mass index, and blood pressure were determined. Anti-PC levels were measured using ELISA. RESULTS: A significant association between low levels of anti-PC at baseline and incident stroke was seen for the whole group of anti-PC levels below the 30th percentile (multivariately adjusted odds ratio, 1.62; CI, 1.11 to 2.35). Analyses of gender-specific associations indicated fairly strong associations for females, especially at the lowest 30th percentile (multivariately adjusted odds ratio, 2.65; CI, 1.41 to 4.95). No associations were noted for men. CONCLUSION: Low anti-PC is a novel independent risk marker for development of stroke. Measurements of anti-PC could be used to identify immunodeficient subjects at an increased risk for stroke. The possibility that such subjects might be targets for novel modes of treatment such as immunotherapies deserves further investigation.
  •  
3.
  • Ekblom, Kim, et al. (författare)
  • Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting.
  • 2010
  • Ingår i: Cerebrovascular Diseases. - Karger. - 1015-9770. ; 30:6, s. 590-596
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Bilirubin, an antioxidant, has been associated with reduced cardiovascular disease risk. A major cause of elevated plasma bilirubin is the common UGT1A1*28 promoter polymorphism in the gene of the bilirubin-conjugating enzyme UDP-glucuronosyltransferase 1A1, which reduces transcription by 70%. Earlier studies reporting a protective effect of bilirubin on stroke have not included analysis of UGT1A1*28. The purpose of this study is to investigate if bilirubin and UGT1A1*28 are protective against ischemic stroke in a prospective case-referent setting. Methods: Cases with first-ever ischemic stroke (n = 231; median lag time 4.9 years) and 462 matched referents from the Northern Sweden Health and Disease Study Cohort were included. Plasma bilirubin was measured and UGT1A1*28 was analyzed by fragment analysis. Results: Plasma bilirubin was lower in cases than in referents, but the difference reached significance only for women. The UGT1A1*28 polymorphism (allele frequency 30%) showed a strong gene-dose relationship with bilirubin levels both among cases and referents, but was not associated with risk for stroke. Among multiple other variables analyzed, the strongest correlation with bilirubin was found for plasma iron. Conclusions: There was no evidence for a protective effect of the UGT1A1*28 polymorphism against stroke and consequently neither for bilirubin. The findings suggest that other factors influencing the risk for stroke might also affect bilirubin levels.
  •  
4.
  • Ekblom, Kim, 1970-, et al. (författare)
  • Bilirubin and UGT1A1*28, are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting
  • ????
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Bilirubin, an antioxidant, has been associated with reduced cardiovascular disease risk. A major cause of elevated plasma bilirubin is the common UGT1A1*28 promoter polymorphism in the gene of the bilirubin-conjugating enzyme UDP-glucuronosyltransferase-1A1, which reduces transcription by 70%. Earlier studies reporting a protective effect of bilirubin on stroke, have not included analysis of UGT1A1*28. The purpose of this study is to investigate if bilirubin and UGT1A1*28 are protective against ischemic stroke in a prospective case-referent setting.Methods: Cases with first-ever ischemic stroke (n=231; median lag time 4.9 years), and 462 matched referents from the The Northern Sweden Health and Disease Study Cohort were included. Plasma bilirubin was measured and UGT1A1*28 was analyzed by fragment analysis.Results: Plasma bilirubin was lower in cases than in referents, but the difference reached significance only for women. The UGT1A1*28 polymorphism (allele frequency 30%), showed a strong gene-dose relationship with bilirubin levels both among cases and referents, but was not associated with risk for stroke. Among multiple other variables analysed the strongest correlation with bilirubin was found for plasma iron.Conclusions: There was no evidence for a protective effect of the UGT1A1*28 polymorphism against stroke and consequently neither for bilirubin. The findings suggest that other factors influencing the risk for stroke also might affect bilirubin levels.
  •  
5.
  • Ekblom, Kim, et al. (författare)
  • Iron Biomarkers in Plasma, HFE Genotypes, and the Risk for Colorectal Cancer in a Prospective Setting
  • 2012
  • Ingår i: Diseases of the Colon & Rectum. - 0012-3706. ; 55:3, s. 337-344
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: High iron levels can increase the formation of noxious oxygen radicals, which are thought to promote carcinogenesis. OBJECTIVE: The aim of this prospective study was to determine whether iron biomarkers and HFE genotypes, which influence iron regulation, constitute risk factors for colorectal cancer. DESIGN: This is a prospective nested case-referent study. SETTINGS: The study was performed within the population-based Northern Sweden Health and Disease Study. PATIENTS: The study included 226 cases of colorectal cancer and 437 matched referents. MAIN OUTCOME MEASURES: Conditional regression analysis was performed. Adjustments for smoking, smoking and BMI, and HFE C282Y and H63D were performed. RESULTS: The highest quintile of total iron-binding capacity showed significantly higher risk for colorectal cancer, unadjusted OR 2.35 (95% CI 1.38-4.02). When stratified by sex, the findings were only present in women (OR 3.34 (95% CI 1.59-7.02)). Ferritin was associated with reduced risk throughout quintiles 2 to 5 both in univariate and multivariate models. LIMITATIONS: Colorectal cancer may influence iron markers because of occult bleeding. Homozygotes for HFE C282Y were too few to make conclusions for this group. The relatively short follow-up time might be insufficient to detect risk of iron biomarkers. CONCLUSIONS: High iron levels do not increase the risk of colorectal cancer. HFE genotypes influencing iron uptake had no effect on colorectal cancer risk.
  •  
6.
  • Ekblom, Kim, 1970-, et al. (författare)
  • Iron stores and HFE genotypes are not related to increased risk of first-time myocardial infarction : a prospective nested case-referent study
  • 2011
  • Ingår i: International Journal of Cardiology. - 0167-5273. ; 150:2, s. 169-172
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives: Our objectives were to study the relationship between iron stores, HFE genotypes and the risk for first-ever myocardial infarction.Methods: First-ever myocardial infarction cases (n=618) and double matched referents from the Northern Sweden Health and Disease Cohort Study were studied in a prospective nested case-referent setting. Plasma iron, total iron binding capacity, transferrin iron saturation and ferritin were analyzed, as well as several confounders. HFE C282Y and H63D genotypes were determined.Results: There was an inverse risk association for myocardial infarction in the highest quartiles of iron (OR 0.68; 95% CI 0.48-0.96) and transferrin iron saturation (OR 0.62; 95% CI 0.42-0.89) in men. This association, however, was lost after adjusting for C-reactive protein. Women homozygous for H63D had a higher risk for myocardial infarction.Conclusions: No risk association between high iron stores and first-ever myocardial infarction was found. The higher risk in female H63D homozygotes is probably not related to iron metabolism.
  •  
7.
  • Ekblom, Kim, 1970-, et al. (författare)
  • Iron stores and HFE genotypes are not related to increased risk of ischemic stroke. : a prospective nested case-referent study
  • 2007
  • Ingår i: Cerebrovascular Diseases. - 1015-9770. ; 24:5, s. 405-411
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: High iron levels can increase the formation of noxious oxygen radicals, which are thought to contribute to cerebrovascular disease. The aim of this prospective study was to determine if iron status and HFE genotypes constitute risk factors for stroke.Methods: First-ever stroke cases (231 ischemic and 42 hemorrhagic) and matched double referents from the population-based Northern Sweden cohorts were studied in a nested case-referent setting.Results: For total iron binding capacity, an increased risk of ischemic stroke was seen in the highest quartile (OR 1.80; 95% CI 1.14-2.83; p for trend 0.012). The highest quartile of transferrin iron saturation showed a decreased risk of ischemic stroke in men (OR 0.44; 95% CI 0.22-0.87; p for trend 0.028), but not in women. There was an increased risk of hemorrhagic stroke in the second (OR 4.07; 95% CI 1.09-15.20) and third quartile (OR 4.22; 95% CI 1.08-16.42) of ferritin. Neither quartiles of plasma iron concentrations nor the HFE C282Y and H63D genotypes were associated with ischemic or hemorrhagic stroke.Conclusions: Iron stores were not positively related to increased risk of ischemic stroke. Furthermore, HFE genotypes did not influence the risk of ischemic or hemorrhagic stroke. Copyright (c) 2007 S. Karger AG, Basel.
  •  
8.
  • Ekblom, Kim, 1970-, et al. (författare)
  • Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective nested case-referent setting
  • 2010
  • Ingår i: Circulation : Cardiovascular Genetics. - Philadelphia, PA : Lippincott Williams & Wilkins. - 1942-325X. ; :3, s. 340-347
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Bilirubin, an effective antioxidant, shows a large variation in levels between individuals and has been positively associated with reduced cardiovascular disease risk. A major reason for the variability is a common promoter polymorphism, UGT1A1*28, which reduces the transcription of the enzyme that conjugates bilirubin, UDP-glucuronosyltransferase 1A1. The aim of the study was to evaluate a possible protective effect of plasma bilirubin and the UGT1A1*28 polymorphism against myocardial infarction in a prospective case-referent setting.Methods and Results: 618 subjects with a first-ever myocardial infarction (median event age 60.5 years, median lag time 3.5 years) and 1184 matched referents were studied. Plasma bilirubin was lower in cases vs. referents. Despite a strong gene-dosage effect on bilirubin levels in both cases and referents, the UGT1A1*28 polymorphism did not influence the risk of myocardial infarction. Among multiple other variables, serum iron showed one of the strongest associations with bilirubin levels.Conclusion: We found no evidence for a protective effect of the UGT1A1*28 polymorphism against myocardial infarction and consequently neither for bilirubin. The lower bilirubin levels in cases might be caused by decreased production, increased degradation or increased elimination.
  •  
9.
  •  
10.
  • Hallmans, Göran, et al. (författare)
  • Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort : evaluation of risk factors and their interactions.
  • 2003
  • Ingår i: Scandinavian Journal of Public Health. Supplement Links. - 1403-4956. ; 61, s. 18-24
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of this paper is, first, to describe the organization, sampling procedures, availability of samples/database, ethical considerations, and quality control program of the Northern Sweden Health and Disease Study Cohort. Secondly, some examples are given of studies on cardiovascular disease and diabetes with a focus on the biomarker programme. The cohort has been positioned as a national and international resource for scientific research.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 29
  • [1]23Nästa
Typ av publikation
Typ av innehåll
refereegranskat (29)
Författare/redaktör
Hallmans, Göran (27)
Hultdin, Johan (11)
Johansson, Ingegerd (9)
Jansson, Jan-Håkan, (8)
Marklund, Stefan L, (7)
visa fler...
Stegmayr, Birgitta (6)
Lindahl, Bernt, (6)
Wiklund, Per-Gunnar, (6)
Johansson, Lars, (4)
Boman, Kurt (4)
Van Guelpen, Bethany ... (4)
Osterman, Pia, (4)
Ekblom, Kim, 1970-, (4)
Söderberg, Stefan, (3)
Winkvist, Anna, 1962 ... (3)
Ekblom, Kim, (3)
Nilsson, Torbjörn, (2)
Hörnell, Agneta, (2)
Rolandsson, Olov, (2)
Nilsson, Torbjörn K (2)
Vessby, Bengt, (2)
Eliasson, Mats, (2)
Palmqvist, Richard (2)
Hallmans, Göran, 194 ... (2)
Söderström, Ingegerd ... (2)
Olsson, Tommy, (2)
Norberg, Margareta (2)
Strand, Magnus, (2)
Thøgersen, Anna M, (2)
Ferrari, P. (1)
Bueno-de-Mesquita, H ... (1)
Linseisen, J (1)
Boeing, H (1)
Clavel-Chapelon, F (1)
Franks, Paul W, (1)
Kaaks, R (1)
Overvad, K (1)
Tumino, R (1)
Riboli, E (1)
Ahren, Bo (1)
Spencer, E. (1)
Johansson, Anders, (1)
Boffetta, P (1)
Nilsson, M (1)
Trichopoulos, D (1)
de Faire, Ulf, (1)
Johansson, G. (1)
Frostegard, Johan (1)
Agren, A. (1)
visa färre...
Lärosäte
Umeå universitet (29)
Göteborgs universitet (4)
Uppsala universitet (3)
Lunds universitet (1)
Högskolan i Halmstad (1)
Örebro universitet (1)
visa fler...
Karolinska Institutet (1)
visa färre...
Språk
Engelska (28)
Ämne (HSV)
Medicin och hälsovetenskap (4)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy